Amlodipine Besylate Tablet
Product Images NDC 71610-938

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 71610-938). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 0938 30)

Label for Amlodipine Besylate USP 10 mg oral tablets, containing 30 tablets. The label includes the NDC number 71610-938-30 and storage instructions to keep the product between 20-25 degrees Celsius and out of reach of children. Manufactured and packaged by Apvera, Inc. and Aphena Pharma, Cookeville, TN.*

FDA Label Image

Aphena (Aphena)

FDA Label Image

Chemical Structure (Image 1)

Chemical structure of amlodipine besylate, displaying the molecular arrangement including aromatic rings, ester groups, and an amine side chain. The molecular formula C20H25ClN2O5 is shown below the structure.*

FDA Label Image

\\client\x$\products\amlodipine Besylate Tabs (076846)\submissions\2017-11-29 Cbe-0 (AJK\Working\INSERT\Image Files\AmlodipineTab-fig01.jpg)

A Kaplan-Meier event rate curve comparing Amlodipine Besylate with placebo over 24 months. The graph plots event rate on the vertical axis against time in months on the horizontal axis, showing a lower event rate for Amlodipine compared to placebo. Included are statistical data: P-value, hazard ratio, and 95% confidence interval.*

FDA Label Image

\\client\x$\products\amlodipine Besylate Tabs (076846)\submissions\2017-11-29 Cbe-0 (AJK\Working\INSERT\Image Files\AmlodipineTab-fig02.jpg)

A forest plot chart showing hazard ratios with 95% confidence intervals comparing effect favorability between Amlodipine and placebo across various patient subgroups, including overall, age groups, gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI-stent strata.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.